AAL
51
-3
SO
55
13
ZTS
34
5
AZO
56
4
NAVI
35
-5
DIS
73
-2
JNJ
33
-12
UNH
45
4
MET
66
3
MU
52
-6
MAS
42
2
HAL
36
-7
ECL
54
5
LNC
28
-2
LMT
29
7
JCI
45
4
TRV
42
2
K
65
2
ADM
22
-2
DUK
60
5
AAL
51
-3
SO
55
13
ZTS
34
5
AZO
56
4
NAVI
35
-5
DIS
73
-2
JNJ
33
-12
UNH
45
4
MET
66
3
MU
52
-6
MAS
42
2
HAL
36
-7
ECL
54
5
LNC
28
-2
LMT
29
7
JCI
45
4
TRV
42
2
K
65
2
ADM
22
-2
DUK
60
5
Financhill
Back

Columbia Research Enhanced Value ETF Vs. Collegium Pharmaceutical Industry Stock Comparison

Sell
34

REVS
Columbia Research Enhanced Value ETF

Last Price:
$24.99
Seasonality Move:
-0.97%
Sell
45

COLL
Collegium Pharmaceutical

Last Price:
$33.33
Seasonality Move:
-1.63%
Sell
34
Columbia Research Enhanced Value ETF (REVS) is a Sell

Is Columbia Research Enhanced Value ETF a Buy, Sell or Hold?

  • The current Columbia Research Enhanced Value ETF [REVS] share price is $24.88. The Score for REVS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • REVS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Collegium Pharmaceutical (COLL) is a Sell

Is Collegium Pharmaceutical a Buy, Sell or Hold?

  • The current Collegium Pharmaceutical [COLL] share price is $33.34. The Score for COLL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REVS Stock Price Chart

What is Columbia Research Enhanced Value ETF's stock price today?

  • The Columbia Research Enhanced Value ETF share price today is $24.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REVS is experiencing buying pressure, which is a positive indicator for future bullish movement.

COLL Stock Price Chart

What is Collegium Pharmaceutical's stock price today?

  • The Collegium Pharmaceutical share price today is $33.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.

REVS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.35 Sell
Relative Strength Index (14 RSI): 37.66 Sell
Chaikin Money Flow: 2215 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.73 - 26.31) Sell
Bollinger Bands (100): (24.74 - 26.2) Sell

COLL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 66.05 Buy
Chaikin Money Flow: 1007158 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.9 - 30.94) Buy
Bollinger Bands (100): (30.52 - 37.92) Sell

REVS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.83 Buy
20-day SMA: 25.23 Sell
50-day SMA: 25.84 Sell
200-day SMA: 24.46 Buy
8-day EMA: 24.9 Sell
20-day EMA: 25.22 Sell
50-day EMA: 25.52 Sell
200-day EMA: 24.51 Buy

COLL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.45 Buy
20-day SMA: 29.79 Buy
50-day SMA: 30.91 Buy
200-day SMA: 34.47 Sell
8-day EMA: 30.02 Buy
20-day EMA: 29.94 Buy
50-day EMA: 31.21 Buy
200-day EMA: 32.94 Buy

Columbia Research Enhanced Value ETF Earnings Growth & REVS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.51 per share.

Columbia Research Enhanced Value ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Collegium Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):